SPIDER FX

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a company representative,foreig report with the FDA on 2020-03-06 for SPIDER FX manufactured by Covidien.

Event Text Entries

[188186154] Journal article: one-day, sequential carotid artery stenting followed by cardiac surgery in patients with severe carotid and cardiac disease journal: vascular medicine year: 2019 ref: doi: 10. 1177/1358863x19872547. Age: average age. Sex: majority gender. Date of event: date of publication journal reported death but there is no information to suggest the device caused or contributed to the death events. Deaths are common occurrences in clinical studies, however the cause(s) of death are often not characterized or clearly associated with a particular product. Therefore, deaths will not be considered reportable unless clearly stated as being associated with a medtronic device. If information is provided in the future, a supplemental report will be issued.
Patient Sequence No: 1, Text Type: N, H10


[188186155] The aim of this study is to evaluate the safety and feasibility of the one-day, sequential approach by carotid artery stenting (cas) immediately followed by cardiac surgery. The study included 70 consecutive patients with ica stenosis coexisting with severe coronary/valve disease, who underwent one-day, sequential cas and cardiac surgery. All cas procedures were performed according to the? Tailored? Algorithm with a substantial use of proximal neuroprotection devices and stents were implanted in most cases. The majority of patients underwent isolated coronary artery bypass grafting or isolated valve replacement. No major adverse cardiac and cerebrovascular events (macce) occurred at the cas stage. There were three perioperative macce: one myocardial infarction and two deaths. All macce were related to cardiac surgery and were due to the high surgical risk profile of the patients. There were 19 non-macce complications. Three non-macce complications were related to cas and were associated with femoral artery puncture: two pseudoaneurysms, managed by local compression/ percutaneous thrombin injection, and one acute right limb ischaemia on the second postoperative day, treated with embolectomy. A further 16 non-macce complications were associated with cardiac surgery. Up to 30 days, no further macce were observed. No perioperative or 30-day neurological complications occurred. In this patient series, one-day, sequential cas and cardiac surgery was relatively safe and did not result in neurological complications. Thus, a strategy of preoperative cas could be considered for patients with severe or symptomatic ica stenosis who require urgent cardiac surgery.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2183870-2020-00068
MDR Report Key9797185
Report SourceCOMPANY REPRESENTATIVE,FOREIG
Date Received2020-03-06
Date of Report2020-03-06
Date of Event2019-09-23
Date Mfgr Received2020-02-27
Date Added to Maude2020-03-06
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactTONI O'DOHERTY
Manufacturer StreetPARKMORE BUSINESS PARK WEST
Manufacturer CityGALWAY
Manufacturer CountryIE
Manufacturer Phone091708734
Manufacturer G1COVIDIEN
Manufacturer Street4600 NATHAN LANE NORTH
Manufacturer CityPLYMOUTH MN 55442
Manufacturer CountryUS
Manufacturer Postal Code55442
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameSPIDER FX
Generic NameCATHETER, CAROTID, TEMPORARY, FOR EMBOLIZATION CAPTURE
Product CodeNTE
Date Received2020-03-06
Lot NumberUNK
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by Mfgr*
Device Sequence No1
Device Event Key0
ManufacturerCOVIDIEN
Manufacturer Address4600 NATHAN LANE NORTH PLYMOUTH MN 55442 US 55442


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2020-03-06

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.